Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-27

Clinical Trial Update: A Study of AND017 to Treat Cancer Related Anemia in Patients Not Receiving Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating AND017 for cancer-related anemia in patients not receiving chemotherapy; the study status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AND017

Snippet

Sponsor: Kind Pharmaceuticals LLC | Conditions: Cancer-Related Anemia | Phase 2 | Status: NOT_YET_RECRUITING